Michael Wolfson, PhD, joined the National Institute for Biomedical Imaging and Bioengineering (NIBIB) in 2016 as a Program Director in the Division of Discovery Science and Technology. He has programmatic oversight of discovery and applied research grants, with emphasis on implantable and assistive medical devices. He is the project team lead for SPARC Component 2 “Next Generation Tools and Technologies”, chair of the NIH National Robotics Initiative and a member of the trans-government NRI effort, a member of BRAIN Initiative Team B: Neural Recording/Modulation Technologies, and a member of the trans-NIH Medical Rehabilitation Coordination Committee. Mike received a Sc.B. degree in electrical engineering from Brown University and a Ph.D. degree in electrical engineering from Cornell University. He is a Senior Member of the IEEE and a member of the Society for Neuroscience. Mike specializes in project management of novel biologic and microscale systems within commercial, small business, and academic R&D environments. His expertise spans multiple disciplines and covers emerging domains, such as bio-, micro-, and nano-system technologies.
- Two Leading Spinal Cord Injury Experts Join ReNetX Scientific Advisory Board
- Get registered for Working 2 Walk 2017 today!
- Airline lobby wins another big delay on reporting data for wheelchair damages and losses *January 2019*
- An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling
- 17th International Symposium on Neural Regeneration
- Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury
- Gait Rehabilitation with a Neurologically Controlled Exoskeleton
- Nanoparticles limit damage in spinal cord injury
- It’s Not a Rat’s Race for Human Stem Cells Grafted to Repair Spinal Cord Injuries
- It’s On! U2FP Working 2 Walk 2017 and SCI Curecast Episode 11
- InVivo Therapeutics restructures and suspends chronic SCI stem cell and gene therapy research programs
- Pretreatment May Unlock the Regenerative Potential of Neural Stem Cells in Chronic Spinal Cord Injury
- Regulateable Chondroitinase ABC gene therapy as a treatment for spinal cord injury
- Miracle chemical ‘cocktail’ could cure spinal cord damage
- Combined expression of pro-regenerative transcription factors and transplanted stem cells to promote corticospinal tract regeneration.
Follow on TwitterMy Tweets